155 related articles for article (PubMed ID: 30209402)
1. CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase.
Hernández-Sánchez M; Kotaskova J; Rodríguez AE; Radova L; Tamborero D; Abáigar M; Plevova K; Benito R; Tom N; Quijada-Álamo M; Bikos V; Martín AÁ; Pal K; García de Coca A; Doubek M; López-Bigas N; Hernández-Rivas JM; Pospisilova S
Leukemia; 2019 Feb; 33(2):518-558. PubMed ID: 30209402
[No Abstract] [Full Text] [Related]
2. Genetic dynamics in untreated CLL patients with either stable or progressive disease: a longitudinal study.
Ramassone A; D'Argenio A; Veronese A; Basti A; Soliman SHA; Volinia S; Bassi C; Pagotto S; Ferracin M; Lupini L; Saccenti E; Balatti V; Pepe F; Rassenti LZ; Innocenti I; Autore F; Marzetti L; Mariani-Costantini R; Kipps TJ; Negrini M; Laurenti L; Visone R
J Hematol Oncol; 2019 Nov; 12(1):114. PubMed ID: 31744508
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.
Baliakas P; Jeromin S; Iskas M; Puiggros A; Plevova K; Nguyen-Khac F; Davis Z; Rigolin GM; Visentin A; Xochelli A; Delgado J; Baran-Marszak F; Stalika E; Abrisqueta P; Durechova K; Papaioannou G; Eclache V; Dimou M; Iliakis T; Collado R; Doubek M; Calasanz MJ; Ruiz-Xiville N; Moreno C; Jarosova M; Leeksma AC; Panayiotidis P; Podgornik H; Cymbalista F; Anagnostopoulos A; Trentin L; Stavroyianni N; Davi F; Ghia P; Kater AP; Cuneo A; Pospisilova S; Espinet B; Athanasiadou A; Oscier D; Haferlach C; Stamatopoulos K;
Blood; 2019 Mar; 133(11):1205-1216. PubMed ID: 30602617
[TBL] [Abstract][Full Text] [Related]
4. Whole-exome and whole-genome sequencing in chronic lymphocytic leukemia: new biomarkers to target.
Hobeika C; Rached G; Chebly A; Chouery E; Kourie HR
Pharmacogenomics; 2020 Aug; 21(13):957-962. PubMed ID: 32799640
[TBL] [Abstract][Full Text] [Related]
5. Chronic lymphocytic leukemia in a young population.
Alshemmari SH; Hamdah A; Pandita R; Kunhikrishnan A
Leuk Res; 2021 Nov; 110():106668. PubMed ID: 34492597
[TBL] [Abstract][Full Text] [Related]
6. Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience.
Spunarova M; Tom N; Pavlova S; Mraz M; Brychtova Y; Doubek M; Panovska A; Skuhrova Francova H; Brzobohata A; Pospisilova S; Mayer J; Trbusek M
Leuk Res; 2019 Jun; 81():75-81. PubMed ID: 31054420
[TBL] [Abstract][Full Text] [Related]
7. Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia.
Ojha J; Ayres J; Secreto C; Tschumper R; Rabe K; Van Dyke D; Slager S; Shanafelt T; Fonseca R; Kay NE; Braggio E
Blood; 2015 Jan; 125(3):492-8. PubMed ID: 25377784
[TBL] [Abstract][Full Text] [Related]
8. Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations.
Blanco G; Puiggros A; Baliakas P; Athanasiadou A; García-Malo M; Collado R; Xochelli A; Rodríguez-Rivera M; Ortega M; Calasanz MJ; Luño E; Vargas M; Grau J; Martínez-Laperche C; Valiente A; Cervera J; Anagnostopoulos A; Gimeno E; Abella E; Stalika E; Hernández-Rivas JM; Ortuño FJ; Robles D; Ferrer A; Ivars D; González M; Bosch F; Abrisqueta P; Stamatopoulos K; Espinet B
Oncotarget; 2016 Dec; 7(49):80916-80924. PubMed ID: 27821812
[TBL] [Abstract][Full Text] [Related]
9. Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia.
Baer C; Dicker F; Kern W; Haferlach T; Haferlach C
Leukemia; 2017 Jun; 31(6):1355-1362. PubMed ID: 27840426
[TBL] [Abstract][Full Text] [Related]
10. The importance of complex karyotype in prognostication and treatment of chronic lymphocytic leukemia (CLL): a comprehensive review of the literature.
Jarošová M; Plevová K; Kotašková J; Doubek M; Pospíšilová Š
Leuk Lymphoma; 2019 Oct; 60(10):2348-2355. PubMed ID: 30773964
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of pathogenesis, prognosis and therapy in chronic lymphocytic leukaemia.
Chen J; McMillan NA
Cancer Biol Ther; 2008 Feb; 7(2):174-9. PubMed ID: 18059180
[TBL] [Abstract][Full Text] [Related]
12. Double IGHV DNA gene rearrangements in CLL: influence of mixed-mutated and -unmutated rearrangements on outcomes in CLL.
Heyman B; Volkheimer AD; Weinberg JB
Blood Cancer J; 2016 Jul; 6(7):e440. PubMed ID: 27367477
[No Abstract] [Full Text] [Related]
13. Biomarkers in chronic lymphocytic leukemia: Clinical applications and prognostic markers.
Amaya-Chanaga CI; Rassenti LZ
Best Pract Res Clin Haematol; 2016 Mar; 29(1):79-89. PubMed ID: 27742074
[TBL] [Abstract][Full Text] [Related]
14. Complex karyotype as a predictor of high-risk chronic lymphocytic leukemia: A single center experience over 12 years.
Kruzova L; Schneiderova P; Holzerova M; Vatolikova M; Divoka M; Turcsanyi P; Urbanova R; Kudelka M; Radvansky M; Kriegova E; Papajik T; Urbankova H
Leuk Res; 2019 Oct; 85():106218. PubMed ID: 31476701
[TBL] [Abstract][Full Text] [Related]
15. Genetics and molecular biology of chronic lymphocytic leukemia.
Carney DA; Wierda WG
Curr Treat Options Oncol; 2005 May; 6(3):215-25. PubMed ID: 15869733
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia.
Mátrai Z; Andrikovics H; Szilvási A; Bors A; Kozma A; Ádám E; Halm G; Karászi É; Tordai A; Masszi T
Pathol Oncol Res; 2017 Jan; 23(1):165-171. PubMed ID: 27757836
[TBL] [Abstract][Full Text] [Related]
17. Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcome.
Steinbrecher D; Jebaraj BMC; Schneider C; Edelmann J; Cymbalista F; Leblond V; Delmer A; Ibach S; Tausch E; Scheffold A; Bloehdorn J; Hallek M; Dreger P; Döhner H; Stilgenbauer S
Leuk Lymphoma; 2018 Jul; 59(7):1614-1623. PubMed ID: 29063805
[TBL] [Abstract][Full Text] [Related]
18. The use of molecular markers in selecting therapy for CLL.
Döhner H
Clin Adv Hematol Oncol; 2005 Feb; 3(2):103-4. PubMed ID: 16166976
[No Abstract] [Full Text] [Related]
19. Identification of altered cell signaling pathways using proteomic profiling in stable and progressive chronic lymphocytic leukemia.
Bagacean C; Iuga CA; Bordron A; Tempescul A; Pralea IE; Bernard D; Cornen M; Bergot T; Le Dantec C; Brooks W; Saad H; Ianotto JC; Pers JO; Zdrenghea M; Berthou C; Renaudineau Y
J Leukoc Biol; 2022 Feb; 111(2):313-325. PubMed ID: 34288092
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
Leukemia; 1997 Apr; 11 Suppl 2():S19-24. PubMed ID: 9178833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
